Liz works with a wide range of biopharmaceutical clients to provide strategic market assessments and analytical insights on a variety of commercial and market access topics.
She has worked across therapeutic areas including oncology, CNS, and rare diseases encompassing several therapeutic approaches such as CAR-T, biosimilars, and vaccines. Liz has experience in demand assessments and modeling, revenue forecasting, value, pricing and access strategy, competitive landscape assessments, physician segmentation, and lifecycle management strategy. She is able to leverage her extensive project management experience leading qualitative, quantitative, and secondary research focused engagements to translate findings into clear, synthesized strategic recommendations for her clients. Liz joined Putnam in 2017 after graduating from Mount Holyoke College with a BA in Economics, a minor in Philosophy, and a focus on Data Sciences.